Charles River Laboratories International

CRLNYSE United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$12.770 B

$267.49 +0.75%

Close of 7 Aug 2026

Revenue

$4.02B

#777 by revenue

Earnings

-$144.3M

Loss-making

Shares outstanding

47,738,872

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch — ranked by market cap

All 12 →

#2IncyteINCY$24.4B
#3MedpaceMEDP$16.5B
#4Charles River Laboratories InternationalCRL$12.8B
#5IconICLR$12.6B
#6AbsciABSI$1.39B

Where these numbers come from

Share counts and financials for Charles River Laboratories International are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.